<DOC>
	<DOCNO>NCT01366599</DOCNO>
	<brief_summary>Describe cardiovascular event cancer population receive highly emetogenic chemotherapy ( HEC ) moderately emetogenic chemotherapy ( MEC ) .</brief_summary>
	<brief_title>CV Events Emetogenic Chemotherapy</brief_title>
	<detailed_description>Patients recruit enrolled study . This study retrospective observational study . Data medical record insurance claim database anonymised use develop patient cohort . All diagnosis treatment record course routine medical practice .</detailed_description>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Emetics</mesh_term>
	<criteria>Enrollment IHCIS 2006 At least one HEC MEC claim 2006 HEC MEC claim three month first HEC/MEC claim `` washin '' period ( i.e . must enrol three month prior first HEC/MEC claim . For patient whose first HEC/MEC event January 1,2006 March 31 , 2006 , enrollment criterion inclusion study may extend far back October 1 , 2005 ) HEC MEC claim prior 45 day last HEC MEC claim `` washout '' period . ( For patient whose last claim 2006 see December 1 , 2006 enrollment 2007 look treatment 45 day `` washout '' period require . )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>highly emetogenic chemotherapy</keyword>
	<keyword>HEC</keyword>
	<keyword>moderately emetogenic chemotherapy</keyword>
	<keyword>MEC</keyword>
</DOC>